Prognostic Impact of Comorbidity in Patients with Bladder Cancer

European Urology

Volumn 53, Issue 3, 2008, Pages 581-589

  Megwalu, Ifeanyichukwu I ^a   Vlahiotis, Anna ^a   Radwan, Mohamed ^a   Piccirillo, Jay F ^a   Kibel, Adam S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bladder cancer; Comorbidity; Cystectomy; Epidemiology; Prognosis

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER CANCER; CANCER CLASSIFICATION; CANCER GRADING; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; CYSTECTOMY; FEMALE; FOLLOW UP; GENDER; HUMAN; INDEPENDENT VARIABLE; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RACE; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS;

AGED; COMORBIDITY; CYSTECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; UNITED STATES; URINARY BLADDER NEOPLASMS;

EID: 38749139288     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.10.069     Document Type: Article

References (26)

1. Millan-Rodriguez F., Chechile-Toniolo G., Salvador-Bayarri J., Palou J., and Vicente-Rodriguez J. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 163 (2000) 73-78
2. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666-675
3. Piccirillo J.F., and Feinstein A.R. Clinical symptoms and comorbidity: significance for the prognostic classification of cancer. Cancer 77 (1996) 834-842
4. Tammemagi C.M., Neslund-Dudas C., Simoff M., and Kvale P. In lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival. J Clin Epidemiol 57 (2004) 597-609
5. Pugliano F.A., Piccirillo J.F., Zequeira M.R., Fredrickson J.M., Perez C.A., and Simpson J.R. Clinical-severity staging system for oral cavity cancer: five-year survival rates. Otolaryngol Head Neck Surg 120 (1999) 38-45
6. Post P.N., Hansen B.E., Kil P.J., Janssen-Heijnen M.L., and Coebergh J.W. The independent prognostic value of comorbidity among men aged < 75 years with localized prostate cancer: a population-based study. BJU Int 87 (2001) 821-826
7. Satariano W.A., and Ragland D.R. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 120 (1994) 104-110
8. Steineck G., Hagman U., Gerhardsson M., and Norell S.E. Vitamin A supplements, fried foods, fat and urothelial cancer. A case-referent study in Stockholm in 1985-87. Int J Cancer 45 (1990) 1006-1011
9. Wingo P.A., Ries L.A., Giovino G.A., et al. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst 91 (1999) 675-690
10. Yusuf S., Hawken S., Ounpuu S., et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366 (2005) 1640-1649
11. Piccirillo J.F., Creech C.M., Zequeira R., Anderson S., and Johnston A.S. Inclusion of comorbidity into oncology data registries. J Reg Manag 26 (1999) 66-70
12. Piccirillo J.F., Tierney R.M., Costas I., Grove L., and Spitznagel Jr. E.L. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 291 (2004) 2441-2447
13. Epstein J.I., Amin M.B., Reuter V.E., et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 12 (1998) 1435-1448
14. Bergkvist A., Ljungqvist A., and Moberger G. Classification of bladder tumors based on the cellular pattern. Acta Chir Scand 130 (1965) 371-378
15. Shariat S.F., Palapattu G.S., Karakiewicz P.I., et al. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur Urol 51 (2007) 137-151
16. Bochner B.H., Cho D., Herr H.W., Donat M., Kattan M.W., and Dalbagni G. Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping. J Urol 172 (2004) 1286-1290
17. Quek M.L., Stein J.P., Clark P.E., et al. Microscopic and gross extravesical extension in pathological staging of bladder cancer. J Urol 171 (2004) 640-645
18. Chatterjee S.J., Datar R., Youssefzadeh D., et al. Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma. J Clin Oncol 22 (2004) 1007-1013
19. Derks W., de Leeuw R.J., and Hordijk G.J. Elderly patients with head and neck cancer: the influence of comorbidity on choice of therapy, complication rate, and survival. Curr Opin Otolaryngol Head Neck Surg 13 (2005) 92-96
20. Clark P.E., Stein J.P., Groshen S.G., et al. Radical cystectomy in the elderly: comparison of survival between younger and older patients. Cancer 103 (2005) 546-552
21. Nielsen M.E., Shariat S.F., Karakiewicz P.I., et al. Bladder Cancer Research Consortium (BCRC). Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 51 (2007) 699-708
22. Miller D.C., Taub D.A., Dunn R.L., Montie J.E., and Wei J.T. The impact of co-morbid disease on cancer control and survival following radical cystectomy. J Urol 169 (2003) 105-109
23. Koch M.O., and Smith Jr. J.A. Influence of patient age and co-morbidity on outcome of a collaborative care pathway after radical prostatectomy and cystoprostatectomy. J Urol 155 (1996) 1681-1684
24. Chang S.S., Alberts G., Cookson M.S., and Smith Jr. J.A. Radical cystectomy is safe in elderly patients at high risk. J Urol 166 (2001) 938-941
25. Sanchez-Ortiz R.F., Huang W.C., Mick R., Van Arsdalen K.N., Wein A.J., and Malkowicz S.B. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol 169 (2003) 110-115
26. Fahmy N.M., Mahmud S., and Aprikian A.G. Delay in the surgical treatment of bladder cancer and survival: systematic review of the literature. Eur Urol 50 (2006) 1176-1182